Genzyme Gets Positive Opinion For Stem Cell Mobilization Drug Mozobil …
(RTTNews) – Friday, Genzyme Corp. (GENZ: News ) said the European Medicines Agency’s Committee for Human Medicinal Products or CHMP has adopted a positive opinion to the marketing authorization application for Mozobil or plerixafor injection. Genzyme …
[Read the full article here]Related News:
Genzyme's Mozobil gets nod for Europe approval
Genzyme Drug Helps Patients Who Need Stem Cell Transplant
Editorials, Opinion Pieces Respond To Obama's Executive Order Lifting Restrictions On Embryonic Stem Cell Research